Rep. Brett Guthrie voted YEA on 100% of 11 bills classified as favoring his top donor sectors—Pharmaceuticals & Biotech and Telecommunications—ranking #4 highest among House members with sufficient tracked votes. He voted YEA on HR3537-117, the "Accelerating Access to Critical Therapies for ALS Act," classified as favoring Pharmaceuticals & Biotech, and supported 4 of 5 bills classified as limiting those same sectors.

EXAMPLE VOTES BEHIND THE NUMBER
HR3537-117 — Accelerating Access to Critical Therapies for ALS Act
HR8454-117 — Medical Marijuana and Cannabidiol Research Expansion Act
S2228-118 — Building Chips in America Act of 2023
FOLLOW THE TRAIL
◈ Ask the Analyst about Brett Guthrie →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 6, 2026 · internal signal score 94/100.